NASDAQ · Drug Manufacturers - Specialty & Generic

PCRX (PCRX) Stock

$25.02 -2.19% NASDAQ: PCRX Healthcare

Valuation

MetricValue
Price$25.02
Market Cap$984.16M
P/E Ratio178.08
P/B Ratio1.37
P/S Ratio1.23
EPS (TTM)$0.13
52-Week High$27.64
52-Week Low$18.80
Dividend Yield0.00%

Financials & Margins

MetricValue
ROE71.00%
ROA1.35%
ROCE4.76%
Gross Margin4.55%
Operating Margin4.55%
Net Margin0.70%
Debt/Equity0.63
Current Ratio4.53

Annual Financials (USD)

Metric20212022202320242025
Revenue$542.0M$667.0M$675.0M$701.0M$726.0M
Operating Profit$90.0M$60.0M$88.0M$-73.0M$33.0M
Net Profit$42.0M$16.0M$42.0M$-100.0M$7.0M
EPS$0.92$0.34$0.89$-2.15$0.16
Op Margin16.6%9.0%13.0%-10.5%4.6%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$2.1B$1.7B$1.6B$1.6B$1.3B
Total Liabilities$1.3B$906.0M$704.0M$775.0M$572.0M
Cash$586.0M$104.0M$153.0M$277.0M$159.0M
Borrowings$1.1B$763.0M$586.0M$639.0M$454.0M

Latest News

PCRX: Lowering target price to $26.00 Argus Research · Jul 15, 2026 Pacira BioSciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire · Jul 8, 2026 PCRX's Exparel Wins Separate Reimbursement From UnitedHealthcare Zacks · Jul 2, 2026 Zimmer Biomet (ZBH) Is Buying Pacira’s Iovera Device And Expanding Into Spasticity Simply Wall St. · Jul 2, 2026 Sector Update: Healthcare Stocks Edge Higher Premarket Wednesday MT Newswires · Jul 1, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$126.0M$145.0M$155.0M$189.0M$152.0M
Investing Cash Flow$-67.0M$-255.0M$62.0M$-94.0M$84.0M
Financing Cash Flow$-10.0M$-1.0M$-2.0M$-59.0M$-154.0M
Net Cash Flow$486.0M$-481.0M$49.0M$123.0M$-118.0M
Free Cash Flow$80.0M$115.0M$139.0M$179.0M$137.0M

Valuation & Return Ratios

MetricValue
PEG Ratio166.33
EV / EBITDA9.58
FCF Yield14.63%
Quick Ratio3.35
Interest Coverage2.20
Return 1Y16.54%
Return 3Y-29.63%
Return 5Y-55.40%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
ANAB $53.61 -1.00% -127.70 $2.31B 0.00%
BBOT $8.09 -4.82% -3.62 $648.07M 0.00%
CRON $2.83 -2.08% -131.00 $1.06B 0.00%
KOD $41.58 -2.16% -8.11 $2.60B 0.00%
MNMDMind Medicine (MindMed) Inc. $20.69 +0.44% -18.83 $1.56B 0.00%

About PCRX

PCRX is led by CEO Frank D. Lee, employs 788 people, headquartered in US, publicly traded since 2011.

PCRX stock trades at $25.02 with a market capitalization of $984.16M. The stock is valued at a price-to-earnings (P/E) ratio of 178.08, price-to-book of 1.37, price-to-sales of 1.23. Over the past 52 weeks the stock has ranged between $18.80 and $27.64, and currently trades 9.5% below its 52-week high.

On profitability, PCRX generates a return on equity (ROE) of 71.00% — well above the market average, a sign of a high-quality business, return on capital employed of 4.76%, an operating margin of 4.55%, a net profit margin of 0.70%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides